Recommendations on the health outcomes of infant formula supplemented with biotics by the ESPGHAN Special Interest Group on Gut Microbiota and Modifications

Documenti analoghi

• Technical review by the ESPGHAN Special Interest Group on Gut Microbiota and Modifications on the health outcomes of infant formula supplemented with prebiotics
  di: Walter Mihatsch, et al.
  Pubblicazione: (2025)
• Technical review by the ESPGHAN Special Interest Group on Gut Microbiota and Modifications on the health outcomes of infant formula supplemented with manufactured human milk oligosaccharides
  di: Iva Hojsak, et al.
  Pubblicazione: (2025)
• Technical review by the ESPGHAN Special Interest Group on Gut Microbiota and Modifications on the health outcomes of infant formula supplemented with postbiotics
  di: Hania Szajewska, et al.
  Pubblicazione: (2025)
• Prebiotics in the management of pediatric gastrointestinal disorders: Position paper of the ESPGHAN special interest group on gut microbiota and modifications
  di: Flavia Indrio, et al.
  Pubblicazione: (2024)
• Reevaluating the FDA's warning against the use of probiotics in preterm neonates: A societal statement by ESPGHAN and EFCNI
  di: Chris H. P. van den Akker, et al.
  Pubblicazione: (2024)